Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_assertion type Assertion NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_head.
- NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_assertion description "[Since adrenomedullin (AM) elicits vasodilatation by binding to specific AM receptors consisted of calcitonin-receptor-like receptor (CRLR)/receptor-activity-modifying protein 2 (RAMP2) or CRLR/receptor-activity-modifying protein 3 (RAMP3) on endothelial cells and stimulating nitric oxide production, AM possibly involves in glomerular capillary dilatation in early phase of diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_provenance.
- NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_assertion evidence source_evidence_literature NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_provenance.
- NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_assertion SIO_000772 14717924 NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_provenance.
- NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_assertion wasDerivedFrom befree-20140225 NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_provenance.
- NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_assertion wasGeneratedBy ECO_0000203 NP925011.RACrSbbNGUrTjR7gPqbRGyZUROpKybVcMCXAX1T_uoAvA130_provenance.